$4 billion revolving credit facility and $600 million delayed draw term loan facility in connection with the combination of Upjohn, a subsidiary of Pfizer, and Mylan in a Reverse Morris Trust transaction

in its sale of shares relating to Match Group in connection with the separation of Match Group and IAC

preferred stock financing led by Qatar Investment Authority

equity private placements, appointment of two new directors and creation of a new Business Review and Evaluation Committee

secondary offering and repurchase of BlackRock stock

public offering of common stock

registered direct offering of common stock

equity offering

Initial public offering

offering of depositary shares, each representing an interest in a share of 5.625% Fixed-Rate Reset Non-Cumulative Perpetual Preferred Stock, Series A

secondary offering and repurchase of its stock held by Sanofi

offering of 5.625% Series F Non-Cumulative Perpetual Preferred Stock